Rabeprazole [`Pariet'] has been approved in a new indication in the European Union

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1264, 2000-01, pp. : 22-22

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

IFN- -1a [`Avonex'; Biogen] has been approved in Canada for use in a new indication

Inpharma, Vol. 1, Iss. 1406, 2003-01 ,pp. : 22-22

Adis International

Access to resources Recommend Favorite

A broad label extension has been approved by the European Commission for bevacizumab [Avastin; Roche].

Inpharma, Vol. 1, Iss. 1624, 2008-01 ,pp. : 22-22

Adis International

Access to resources Recommend Favorite

Levetiracetam [Keppra; UCB] has been approved by the European Commission for the treatment of partial onset seizures

Inpharma, Vol. 1, Iss. 1552, 2006-01 ,pp. : 23-23

Adis International

Access to resources Recommend Favorite

Lamivudine [`Zeffix'; Glaxo Wellcome] has been launched in a new indication in New Zealand

Inpharma, Vol. 1, Iss. 1259, 2000-01 ,pp. : 21-21

Adis International

Access to resources Recommend Favorite

Health Canada has approved pergolide [`Permax'; Draxis Health] for use in a new indication;

Inpharma, Vol. 1, Iss. 1263, 2000-01 ,pp. : 22-22

Adis International

Access to resources Recommend Favorite